Genmab Relies on IDBS’ ActivityBase XE for Analyzing Results from Its Discovery Activities Therapeutic monoclonal antibodies are the fastest growing segment within the pharmaceutical market. Among ...

MELVILLE, N.Y.--(BUSINESS WIRE)--Accio Data, the background screening industry’s leading enterprise platform provider, and Intellicheck, Inc. (Nasdaq: IDN), an industry-leading identity company ...

Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO) Cancer is the second leading cause of death globally. However, by ...

The mean monthly screening volume increased 955% in individuals aged 45 to 49 years, compared to 46% in individuals aged 50 to 75 years, study researchers reported.

A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term ...

Science Progress (1933-), Vol. 104, No. 3 (2021), pp. 1-10 (10 pages) Objectives: This study aimed to evaluate the truthfulness of patients about their pre-appointment COVID-19 screening tests at a ...

“The latest results show that PSA screening in this trial prevented 22 prostate cancer deaths per 10,000 men screened, compared to 14 deaths in the previous analysis. It also shows that the harms of ...

This round enables Castellum.AI to integrate more deeply with financial institutions, enabling compliance teams to quickly access our secure, effective and explainable AI. NEW YORK--(BUSINESS ...

Purdue University runs on data. It’s the force that enables decision-making, guides assessment and evaluation, and provides the basis for continuous improvement. And a huge chunk of it is collected, ...